SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.36+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mudcat who wrote (25638)9/22/1998 10:10:00 AM
From: Henry Niman  Read Replies (1) of 32384
 
From the H&Q report (on 2Q, 1998) of Aug 19, 1998:
"We expect both of these products to be approved by year end 1998, and for launch to occur shortly thereafter."

From yesterday's (Sept 21, 1998) spot report:
"We expect topical Panretin and ONTAK to be approved by year end 1998, and for launch to occur shortly thereafter."

The language in the Aug 19 report looks pretty close to yesterday's reiterated BUY by H&Q.

I think that the news is that they are sticking to their earlier (Aug 19) timetable.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext